Personal Construct Therapy vs Cognitive Behavioral Therapy in the Treatment of Depression in Women with Fibromyalgia: Study Protocol for a Multicenter Randomized Controlled Trial

dc.contributor.author
Paz, Clara
dc.contributor.author
Aguilera, María del Carmen
dc.contributor.author
Salla Martínez, Marta
dc.contributor.author
Compañ, Victoria
dc.contributor.author
Medina Alcaraz, Juan Carlos
dc.contributor.author
Bados López, Arturo
dc.contributor.author
García Grau, Eugeni
dc.contributor.author
Castel, Antoni
dc.contributor.author
Cañete Crespillo, Josep
dc.contributor.author
Montesano del Campo, Adrián
dc.contributor.author
Madeiros-Ferreira, L.
dc.contributor.author
Feixas i Viaplana, Guillem
dc.date.issued
2020-09-17T16:20:52Z
dc.date.issued
2020-09-17T16:20:52Z
dc.date.issued
2020-06
dc.date.issued
2020-09-17T16:20:53Z
dc.identifier
1176-6328
dc.identifier
https://hdl.handle.net/2445/170709
dc.identifier
699335
dc.identifier
32021219
dc.description.abstract
Background: Fibromyalgia (FM) is a debilitating syndrome, more prevalent in women, which is aggravated by the presence of depressive symptoms. In the last decade, cognitive behavioral therapy (CBT) has demonstrated to reduce such depressive symptoms and pain in these patients, but there are still a considerable number of them who do not respond to interventions. The complexity of the disorder requires the consideration of the unique psychological characteristics of each patient to attain good outcomes. One approach that could accomplish this goal might be personal construct therapy (PCT), an idiographic approach that considers identity features and interpersonal meanings as their main target of intervention. Then, the aim of the study is to test the efficacy of PCT as compared to a well-established treatment in the reduction of depressive symptoms in women with fibromyalgia. Methods and Analysis: This is a multicenter randomized controlled trial. In each condition participants will attend up to eighteen 1-hr weekly therapy sessions and up to three 1-hr booster sessions during the following 3- 5 months after the end of treatment. The depression subscale of the Hospital Anxiety and Depression Scale (HADS-D) will be the primary outcome measure and it will be assessed at baseline, at the end of therapy, and at 6-month follow-up. Other secondary measures will be applied following the same schedule. Participants will be 18- to 70-years-old women with a diagnosis of FM, presenting depressive symptoms evinced by scores above seven in depression items of the HADS-D. Intention-to-treat and complete case analyses will be performed for the main statistical tests. Linear mixed models will be used to analyze and to compare the treatment effects of both conditions.
dc.format
11 p.
dc.format
application/pdf
dc.language
eng
dc.publisher
Dove Medical Press
dc.relation
Reproducció del document publicat a: https://doi.org/10.2147/NDT.S235161
dc.relation
Neuropsychiatric Disease and Treatment, 2020, vol. 16, p. 301-311
dc.relation
https://doi.org/10.2147/NDT.S235161
dc.rights
cc-by-nc (c) Paz, C. et al., 2020
dc.rights
http://creativecommons.org/licenses/by-nc/3.0/es
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Cognició, Desenvolupament i Psicologia de l'Educació)
dc.subject
Teoria dels constructes personals
dc.subject
Teràpia cognitiva
dc.subject
Fibromiàlgia
dc.subject
Depressió psíquica
dc.subject
Personal construct theory
dc.subject
Cognitive therapy
dc.subject
Fibromyalgia
dc.subject
Mental depression
dc.title
Personal Construct Therapy vs Cognitive Behavioral Therapy in the Treatment of Depression in Women with Fibromyalgia: Study Protocol for a Multicenter Randomized Controlled Trial
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.